Uncategorized

MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization

Published

on

As MeiraGTx lines up the pieces for a commercial push, the company has new funding to work with.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version